Related Experiment Video
Updated: Jan 8, 2026
10:24
Recording and Modulation of Epileptiform Activity in Rodent Brain Slices Coupled to Microelectrode Arrays
Published on: May 15, 2018
15.3K
Calcium-Activated Potassium Channel KCa3.1 Shape Epileptiform Discharges in the Rodent Entorhinal Cortex
Elena B Soboleva1, Dmitry V Amakhin1, Denis S Sinyak1
1Sechenov Institute of Evolutionary Physiology and Biochemistry, RAS, Saint Petersburg, 194223, Russian Federation.
Molecular Neurobiology
|December 11, 2025
Summary
Potassium calcium-activated channels (KCa3.1) play a role in epilepsy. Upregulating these channels may help terminate seizure-like events, offering a potential therapeutic target.
Area of Science:
- Neuroscience
- Channel Physiology
- Epilepsy Research
Background:
- Epileptic discharge mechanisms are not fully understood.
- The role of KCa3.1 (KCNN4) channels in epilepsy requires further investigation.
Purpose of the Study:
- To investigate the role of KCa3.1 channels in modulating epileptiform activity in the entorhinal cortex.
- To explore KCa3.1 channel function in different epilepsy models and neuronal types.
Main Methods:
- Whole-cell patch-clamp recordings in rodent brain slices.
- Utilized two in vitro epilepsy models: late recurrent discharges (LRDs) and seizure-like events (SLEs).
- Pharmacological manipulation (TRAM-34, NS-309) and genetic manipulation (KCNN4 overexpression) were employed.
Main Results:
- KCa3.1 channel blockade increased neuronal excitability.
- KCa3.1 modulation affected LRDs and SLEs differently, with greater impact on SLEs.
- Overexpression of KCNN4 in glutamatergic neurons reduced LRD duration and magnitude.
- KCa3.1 upregulation appears to facilitate the termination of epileptiform discharges.
Conclusions:
- KCa3.1 channel contribution to epileptiform activity is dependent on its temporal pattern.
- KCa3.1 channels act as feedback mechanisms for premature termination of epileptiform discharges.
- KCa3.1 channels represent a potential therapeutic target for epilepsy treatment.
Keywords:
Entorhinal cortexEpileptiform dischargesKCNN4 gene therapyKCa3.1 channelsNeuronal hyperexcitabilityTRAM-34More Related Videos
Related Concept Videos
01:19The Role of Ion Channels in Neuronal Computation
3.6K
A postsynaptic neuron usually receives numerous impulses from several other presynaptic neurons. The axon hillock of the postsynaptic neuron integrates all these signals and determines the likelihood of firing an action potential.
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential....
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential....
3.6K
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.1K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.1K
01:20Antiepileptic Drugs: Potassium Channel Activators
603
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
603